doi: 10.1016/0304-3959(86)90066-7
Even in India, early access to innovator brands like Novo Nordisk Ozempic and Wegovy (both semaglutide), plus Rybelsus, Victoza, and Trulicity, meant bills of 10,00020,000 per month for many patients, putting these drugs out of reach for the average middle-class household
Orlistat remains the only oral weight-loss medication currently NHS-licensed for obesity, but it works differently and produces around 3% weight loss, compared to the 11% to 14% reported for the GLP-1 pills
Physicians guide duration decisions based on progress, health status, weight maintenance ability, and patient preferences
This 12,000 square meter facility has two state-of-the-art production lines designed for filling vials and pre-filled syringes with an annual capacity of 26 million product units.Skyepharmas projected annual revenues from oncology-linked activities touched 10 million (US$ 11.2 million)